Lead inhibits 1,25-dihydroxyvitamin D-3 regulation of calcium metabolism in osteoblastic osteosarcoma cells (ROS 17/2.8)
- 10 December 1992
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1180 (2) , 187-194
- https://doi.org/10.1016/0925-4439(92)90067-w
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 172.8) cellsToxicology and Applied Pharmacology, 1990
- Nanomolar concentrations of lead selectively block neuronal nicotinic acetylcholine responses in mouse neuroblastoma cellsToxicology and Applied Pharmacology, 1990
- Cellular lead toxicity and metabolism in primary and clonal osteoblastic bone cellsToxicology and Applied Pharmacology, 1990
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- Longitudinal Analyses of Prenatal and Postnatal Lead Exposure and Early Cognitive DevelopmentNew England Journal of Medicine, 1987
- Tumour‐promoting phorbol esters inhibit agonist‐induced phosphatidate formation and Ca2+ flux in human plateletsFEBS Letters, 1985
- Protein kinase C regulation of the receptor-coupled calcium signal in histamine-secreting rat basophilic leukaemia cellsNature, 1985
- Relationship Between Ca2+ Uptake and Catecholamine Secretion in Primary Dissociated Cultures of Adrenal MedullaJournal of Neurochemistry, 1982
- Effect of lead on calcium homeostasis in the isolated rat hepatocyteToxicology and Applied Pharmacology, 1982
- Reduction in 1,25-Dihydroxyvitamin D in Children with Increased Lead AbsorptionNew England Journal of Medicine, 1980